WO2015084693A3 - Nouveau procédé de préparation de loratadine à partir d'un intermédiaire de cétone - Google Patents

Nouveau procédé de préparation de loratadine à partir d'un intermédiaire de cétone Download PDF

Info

Publication number
WO2015084693A3
WO2015084693A3 PCT/US2014/067846 US2014067846W WO2015084693A3 WO 2015084693 A3 WO2015084693 A3 WO 2015084693A3 US 2014067846 W US2014067846 W US 2014067846W WO 2015084693 A3 WO2015084693 A3 WO 2015084693A3
Authority
WO
WIPO (PCT)
Prior art keywords
loratadine
ketone intermediate
new process
active carbon
salt
Prior art date
Application number
PCT/US2014/067846
Other languages
English (en)
Other versions
WO2015084693A2 (fr
Inventor
Richard Desmond
Jungchul Kim
Robert A. Reamer
Jacob H. Waldman
Feng Xu
Original Assignee
Merck Sharp & Dohme Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Corp. filed Critical Merck Sharp & Dohme Corp.
Publication of WO2015084693A2 publication Critical patent/WO2015084693A2/fr
Publication of WO2015084693A3 publication Critical patent/WO2015084693A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention se rapporte à un procédé de synthèse de dernière étape destiné à fabriquer de la loratadine à partir d'un intermédiaires de cétone.
PCT/US2014/067846 2013-12-05 2014-12-01 Nouveau procédé de préparation de loratadine à partir d'un intermédiaire de cétone WO2015084693A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361912133P 2013-12-05 2013-12-05
US61/912,133 2013-12-05

Publications (2)

Publication Number Publication Date
WO2015084693A2 WO2015084693A2 (fr) 2015-06-11
WO2015084693A3 true WO2015084693A3 (fr) 2015-10-22

Family

ID=53274263

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/067846 WO2015084693A2 (fr) 2013-12-05 2014-12-01 Nouveau procédé de préparation de loratadine à partir d'un intermédiaire de cétone

Country Status (1)

Country Link
WO (1) WO2015084693A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016206028A1 (fr) * 2015-06-24 2016-12-29 苏州大学张家港工业技术研究院 Procédé de préparation de phosphate de cyclopropyle
CN106478595B (zh) * 2016-09-18 2019-05-21 西安交通大学 氯雷他定晶型及其制备方法和用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271378B1 (en) * 1998-12-18 2001-08-07 Schering Corporation Process for preparing tricyclic compounds having antihistaminic activity
US20080194823A1 (en) * 2006-04-04 2008-08-14 Mayur Devjibhai Khunt Preparation of loratadine form i
US7449583B2 (en) * 2001-11-05 2008-11-11 Zach System S.P.A. Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine)
CN102336739A (zh) * 2011-07-15 2012-02-01 海南灵康制药有限公司 一种氯雷他定化合物及其制法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271378B1 (en) * 1998-12-18 2001-08-07 Schering Corporation Process for preparing tricyclic compounds having antihistaminic activity
US7449583B2 (en) * 2001-11-05 2008-11-11 Zach System S.P.A. Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine)
US20080194823A1 (en) * 2006-04-04 2008-08-14 Mayur Devjibhai Khunt Preparation of loratadine form i
CN102336739A (zh) * 2011-07-15 2012-02-01 海南灵康制药有限公司 一种氯雷他定化合物及其制法

Also Published As

Publication number Publication date
WO2015084693A2 (fr) 2015-06-11

Similar Documents

Publication Publication Date Title
JOP20200225A1 (ar) مشتق كوينولين عالي النقاء وطريقة لإنتاجه
IL240030A0 (en) 2-aza-bicyclo[1.2.2]heptane-3-carboxylic acid (benzyl-cyano-methyl)-modified amides inhibitors of cathepsin c
MY194307A (en) Pyridone derivative having tetrahydropyranylmethyl group
IN2015KN00262A (fr)
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
WO2016016766A3 (fr) Procédé de préparation d'isavuconazonium ou de son sel
CA2899024C (fr) Formes cristallines d'acide {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetique
WO2015068175A3 (fr) Procédé perfectionné de préparation de pazopanib ou d'un sel de qualité pharmaceutique de celui-ci
MX2016002718A (es) Derivados de ceto-imidazopiridina como moduladores del receptor huerfano relacionado con receptor retinoide (porc).
MX2016004963A (es) Sal y formas cristalinas de inhibidores de quinasa tipo polo-4.
NZ718607A (en) Synthetic route to 2’-deoxy-2’,2’-difluorotetrahydrouridines
CA2922375C (fr) Formes de sels d'alpha-tea: compositions et utilisations therapeutiques
FR2972452B1 (fr) Procede de preparation du difluoroacetonitrile et de ses derives
MY185367A (en) Improved process for the preparation of osimertinib (azd9291) or a salt thereof, and ?azd9291 aniline? or a salt thereof
FR3007425B1 (fr) Nouveau procede de fabrication d'acide formique
WO2012140490A3 (fr) Procédé de préparation de dérivé de quinoléine
BR112019001447A2 (pt) método de produção para composto pirazol-amida
MX2018007415A (es) Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
IN2014DN10680A (fr)
WO2015084693A3 (fr) Nouveau procédé de préparation de loratadine à partir d'un intermédiaire de cétone
WO2015199418A3 (fr) Nouveau composé hétérocyclique
PH12017500435A1 (en) A salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof
EP3366641A4 (fr) Procédé pour la production de solution aqueuse purifiée d'acide silicique
IN2013MU04056A (fr)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14867441

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14867441

Country of ref document: EP

Kind code of ref document: A2